The latest closing stock price for EYEPOINT PHARMACEUTICALS, INC as of February 21, 2025 is 6.15.
An investor who bought $1,000 worth of EYEPOINT PHARMACEUTICALS, INC stock at the IPO in 2018 would have $-465 today, roughly 0 times their original investment - a -8.55% compound annual growth rate over 7 years.
The all-time high EYEPOINT PHARMACEUTICALS, INC stock closing price was 37.70 on October 03, 2018.
The EYEPOINT PHARMACEUTICALS, INC 52-week high stock price is 29.31, which is 376.6% above the current share price.
The EYEPOINT PHARMACEUTICALS, INC 52-week low stock price is 5.90, which is 4.1% below the current share price.
The average EYEPOINT PHARMACEUTICALS, INC stock price for the last 52 weeks is 11.51.
An investor who bought $1,000 worth of EYEPOINT PHARMACEUTICALS, INC stock at the IPO in 2018 would have $-465 today, roughly 0 times their original investment - a -8.55% compound annual growth rate over 7 years.
The all-time high EYEPOINT PHARMACEUTICALS, INC stock closing price was 37.70 on October 03, 2018.
The EYEPOINT PHARMACEUTICALS, INC 52-week high stock price is 29.31, which is 376.6% above the current share price.
The EYEPOINT PHARMACEUTICALS, INC 52-week low stock price is 5.90, which is 4.1% below the current share price.
The average EYEPOINT PHARMACEUTICALS, INC stock price for the last 52 weeks is 11.51.